Brain Flight – ein Computerspiel unterstützt die Gehirnforschung

After we’ve had an interview with the amazing and insightful Dr. Bryan Vartebedian as well as the inspirational Lisa Chu, we thought that we should also talk to somebody who’s on the pharma side of the healthcare industry. Dr. Andreas Amrein, who is the Senior Area Director for the Diabetes Unit of Abbott in Asia Pacific, thankfully took some time to answer our questions on the intersection of technology and diabetes. Diabetes is clearly a prevalent problem in civilized countries and to us it seems that pharmaceutical companies are still slow in developing disruptive technological solutions for diabetic patients. Andreas, who was originally trained as a phycisist as the prestigious ETH in Zuerich, has some insights on how a globally acting pharmaceutical company thinks about a global healthcare problem and its solution within healthcare. Initially, the contact between Andreas and MedCrunch came from the Virtual Pharma Summit, where Andreas and MedCrunch will participate in a virtual round table. Join the event here and have fun with the interview! MedCrunch: Dear Mr. Amrein, thanks for your time. To give us and our readers a little background, please let us know how you came into the pharmaceutical business. Originally I am a […]